Eurosurveillance · 2019 · 93 citations · 14 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceInfectious Disease EpidemiologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Resistance GenomicsBacterial InfectionsCarbapenem ResistanceCombination Antimicrobial TherapyMultidrug ResistanceAntibiotic-resistant Pathogen ControlCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenem Resistance SurveillanceCarbapenemase EnzymesKlebsiella Pneumoniae CarbapenemaseKlebsiella Pneumoniae ResistanceSpectrum Of Carbapenems
From June to October 2019, 17 patients (six infected, 11 colonised) with an extensively drug-resistant (XDR) Klebsiella pneumoniae strain were notified from four Western Pomerania medical facilities. The XDR K. pneumoniae produced carbapenemases NDM-1 and OXA-48, and was only susceptible to chloramphenicol, tigecycline and cefiderocol. Synergistic activity was observed for the combination of aztreonam plus ceftazidime-avibactam. Genomic analyses showed all isolates belonged to K. pneumoniae sequence type 307. Control measures and further investigations are ongoing.
14
Identification of acquired antimicrobial resistance genes
Ea Zankari, Henrik Hasman, Salvatore Cosentino et al. · Journal of Antimicrobial Chemotherapy · 2012 · 5.2K citations · Full text
Identification of Klebsiella capsule synthesis loci from whole genome data
Kelly L. Wyres, Ryan R. Wick, Claire L. Gorrie et al. · Microbial Genomics · 2016 · 572 citations · Full text